Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Transl Med. Aug 12, 2014; 3(2): 58-68
Published online Aug 12, 2014. doi: 10.5528/wjtm.v3.i2.58
Table 1 Major studies that compared donation after cardiac death vs donation after brain death liver transplantation outcomes
Ref.YearDCD transplants numberRecipient survival rate (%) at 1 yr, 3 yr, and 5 yr post-transplantGraft survival rate (%) at 1 yr, 3 yr, and 5 yr post-transplantITBS rateRetransplants rate
Croome et al[98]2013HCC DCD = 242766456
Non-HCC DCD = 2117867771
Abt et al[33]20131104714%
Callaghan et al[99]20133528173
Vanatta et al[100]201338928092747%2%
Elaffandi et al[101]2012108842%
Taner et al[28]201220093858181736912%5%
Meurisse et al[52]2012309385859082823%
DeOliveira et al[30]20111678785818583782%
Hong et al[102]20118178625310%12%
Mathur et al[53]201115676513%
Dubbled et al[46]2010558580746814%18%
Yamamoto et al[45]201024624343543738
Detry et al[103]2010588367724938%
de Vera et al[27]20091417970695616%18%
Grewal et al[43]20091089288887974718%15%
Jiménez-Galanes et al[104]20092086805%
Pine et al[105]2009398268806420%
Nguyen et al[42]2009199090746310%16%
Fujita et al[106]2007248782695621%
Table 2 Hypothermic vs normothermic machine perfusion of liver grafts
Hypothermic machine perfusion HMPNormothermic machine perfusion NMP
Temperature 0 °C-4 °CTemperature 37 °C
Logistically easierLogistically demanding
Modest resumption of energy production with low perfusion rate
Improves the state of mitochondria during preservationRecreates the physiological milieu by maintenance of normal temperature
Performed at sub-physiologic pressures[107]Performed at physiological pressures[70,82]
Requires low perfusion rates[108]Requires high perfusion rates[108]
No requirement for a specific oxygen carrier in the perfusate as demand for O2 is low[108]Oxygen is provided by using blood, modified hemoglobin, or using a high oxygen tension in special preservation solutions[70,82,84,88,109]
Less occurrence of graft infection considering the hypothermic state More tendency for endothelial cell, kupffer cell, and macrophage cell damage due to shear stress and hypothermic activation[110-113]Reduces IRI
When compared to SCS it decreases inflammatory cytokines but no difference in graft or patient survival was found[77,114]Provides nutrients (glucose, amino acids, etc.), medications to prevent micro-circulatory failure (e.g., prostacyclin, heparin, antibiotics), and oxygen
May help protect marginal livers by converting PNF into allograft dysfunction[71]Allows the assessment of organ viability (e.g., Galactose elimination, factor V production, bile flow)
May allow the use of gene therapy prior to transplantation, to reduce the risk of rejection, or decrease the ischemia-reperfusion injury[115-117]